Anthropic Ships Sonnet 5 With Agentic Safety and Pricing Details
1 July 20265 min read
Illustrative image. Cedar S. Insights uses editorial stock photography; images do not depict specific events described in articles.
The US Food and Drug Administration updated its Digital Health Center of Excellence page on 24 April with the launch of the Technology-Enabled Meaningful Patient Outcomes pilot for digital health devices.
The FDA tied the pilot to the Center for Medicare and Medicaid Innovation's ACCESS model, which is aimed at chronic-care approaches that can be effective and scalable. For device makers, the message is that evidence, reimbursement and safety review are converging.
The important detail is not that every app-like medical product is suddenly approved. It is that regulators are trying to test how software-driven devices can reach patients without treating market access and patient safety as separate worlds.
Why It Matters
Digital health tools often fail between clinical promise and reimbursement reality. A pilot linking device evidence, chronic care and payment models may shape which technologies can scale in real care settings.
What to Watch
Watch which device categories join the pilot, what outcome measures are required, and whether CMS payment experiments create a path for wider adoption.
Primary Sources
Our sourcing: Cedar S. Insights provides source-led editorial analysis. Reported company, institutional and regulatory claims are attributed to their original sources unless stated otherwise.
Corrections: If a material factual error is identified, Cedar S. Insights will update the relevant article and preserve the distinction between the corrected statement and supporting evidence.
Topics
FDADigital HealthMedical DevicesChronic Care